Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

2.

Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).

McNaughton A, Frasca S Jr, Mishra N, Tuttle AD.

J Zoo Wildl Med. 2014 Dec;45(4):987-90.

PMID:
25632699
3.

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.

Blood Pressure Lowering Treatment Trialists' Collaboration, Ying A, Arima H, Czernichow S, Woodward M, Huxley R, Turnbull F, Perkovic V, Neal B.

Lancet. 2015 Mar 7;385(9971):867-74. doi: 10.1016/S0140-6736(14)61171-5. Epub 2014 Nov 4.

PMID:
25468168
4.

Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.

Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.

J Vet Intern Med. 2013 Nov-Dec;27(6):1452-62. doi: 10.1111/jvim.12217. Epub 2013 Oct 15.

5.

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

Blood Pressure Lowering Treatment Trialists' Collaboration, Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N, Woodward M, MacMahon S.

BMJ. 2013 Oct 3;347:f5680. doi: 10.1136/bmj.f5680. Review.

6.

The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.

Woźniak M, Tyrankiewicz U, Drelicharz L, Skórka T, Jabłońska M, Heinze-Paluchowska S, Chłopicki S.

Kardiol Pol. 2013;71(7):730-7. doi: 10.5603/KP.2013.0161.

7.

Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.

Lim WY, Woldman S.

Br J Hosp Med (Lond). 2013 Feb;74(2):C18-22. Review. No abstract available.

PMID:
23411909
8.

Treatment of isolated systolic hypertension in the elderly.

Duprez D.

Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1367-73. doi: 10.1586/erc.12.117. Review.

PMID:
23244357
9.

How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?

Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, Davis BR, Alderman MH, Gordon D, Furberg CD, Franklin SS, Blumenthal SS, Castaldo RS, Preston RA; LHAT Collaborative Research Group.

Stat Med. 2013 Feb 28;32(5):884-97. doi: 10.1002/sim.5580. Epub 2012 Sep 7.

PMID:
22961832
10.

Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.

Peters R, Beckett N, Poulter R, Burch L, Narkiewicz K, Fagard R, Nitsch D, Wang N, Li M, Fletcher A, Bulpitt C.

Age Ageing. 2013 Mar;42(2):253-8. doi: 10.1093/ageing/afs109. Epub 2012 Aug 21.

12.

Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.

Alagiakrishnan K, Banach M, Jones LG, Datta S, Ahmed A, Aronow WS.

Ann Med. 2013 Feb;45(1):37-50. doi: 10.3109/07853890.2012.660493. Epub 2012 Mar 13. Review.

PMID:
22413912
13.

Current approaches to the treatment of hypertension in older persons.

Aronow WS.

Postgrad Med. 2012 Jan;124(1):50-9. doi: 10.3810/pgm.2012.01.2517. Review.

PMID:
22314114
14.

South African hypertension guideline 2011.

Seedat YK, Rayner BL; Southern African Hypertension Society.

S Afr Med J. 2011 Dec 14;102(1 Pt 2):57-83. Erratum in: S Afr Med J. 2012 Feb;102(2):94.

PMID:
22273141
15.

Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.

Ito H, Ishii K, Kihara H, Kasayuki N, Nakamura F, Shimada K, Fukuda S, Iwakura K, Yoshikawa J; Effect of ARB/Diuretics on Diastolic Function in Patients with Hypertension (EDEN) trial investigators.

Hypertens Res. 2012 Jan;35(1):93-9. doi: 10.1038/hr.2011.169. Epub 2011 Oct 20.

16.

ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.

De Vecchis R, Di Biase G, Ariano C, Cioppa C, Giasi A, Ciccarelli A, Pucciarelli A, Cantatrione S.

Arq Bras Cardiol. 2011 Dec;97(6):507-16. Epub 2011 Oct 14. English, Portuguese.

17.

Thiazide and loop diuretics.

Sica DA, Carter B, Cushman W, Hamm L.

J Clin Hypertens (Greenwich). 2011 Sep;13(9):639-43. doi: 10.1111/j.1751-7176.2011.00512.x. Epub 2011 Jul 27. Review.

PMID:
21896142
18.

Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?

Oghlakian GO, Sipahi I, Fang JC.

Mayo Clin Proc. 2011 Jun;86(6):531-9. doi: 10.4065/mcp.2010.0841. Epub 2011 May 16. Review.

19.

Achieving blood preSsure goals sTudy in uncontrolled hypeRtensive pAtients treated with a fixed-dose combination of ramipriL/hydrochlorothiazide: the ASTRAL study.

Okpechi IG, Schoeman HS, Longo-Mbenza B, Oke DA, Kingue S, Nkoua JL, Rayner BL.

Cardiovasc J Afr. 2011 Mar-Apr;22(2):79-84. doi: DOI: CVJ-21.069.

20.

Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF.

Schou M, Valeur N, Torp-Pedersen C, Gustafsson F, Køber L.

Eur J Clin Invest. 2011 Nov;41(11):1237-44. doi: 10.1111/j.1365-2362.2011.02532.x. Epub 2011 May 6.

PMID:
21554269
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk